ImmunoGen,
Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted
antibody-based anticancer products, today announced that the following
presentations by Company management ... read more
ImmunoGen,
Inc. (Nasdaq: IMGN), a biotechnology
company that develops targeted antibody-based anticancer products, today
announced that the Company will host a conference ... read more